Enjoy!
A blog from WHSLA (Wisconsin Health Sciences Library Association) featuring posts on medical and health science libraries, NLM, and learning opportunities for medical and health science librarians and library staff.
Enjoy!
MLA identifies three reasons for discontinuing their hybrid meetings, which I've summarized below. If you would like to see MLA's statement, verbatim, please refer to the MLA Connect post.
"Make your contribution and help shape the future of health information. Whether you have developed a successful program, conducted innovative research, implemented a new service, or want to facilitate a deep discussion on an emerging issue, submit a proposal on contributed content at MLA '27" -MLA
Below are the criteria for posters and immersion sessions, pasted directly from this MLA Connect post.
OpenEvidence is a large language model (LLM) grounded in the medical literature, with its website self-identifying as an "AI copilot for doctors that helps them make high-stakes decisions at the point of care." The free tool has become increasingly popular within the health sciences, with its website boasting that "This year, more than 100 million Americans will be treated by a clinician using OpenEvidence."
Up until now, OpenEvidence accounts have been restricted to health care professionals with a National Provider Identifier (NPI) or students that provide proof of enrollment to a health sciences college or university, which has made evaluation of the tool particularly challenging for librarians (but even that hasn't stopped us: Exhibits A and B. Librarians are a tenacious bunch!😉).
However, at long last (and likely in consequence of tenacious librarians spamming their inboxes), OpenEvidence has quietly opened account access to medical librarians. Now, librarians have the option to register as a "medical librarian" so long as they upload proof of their current position title and employment (I was able to create my account by uploading a screenshot of my public staff page, which includes my photo and my position as a health sciences librarian). Not only does this give you unlimited queries (without an account you were only allotted 2 or 3 queries per week), but it gives you access to additional tools in OpenEvidence, such as their calculators, clinical trials locators, etc.
For those who have seen one of our Wild West presentations or our MLA poster session, or read our article on OpenEvidence, you've likely gotten the impression that my colleagues and I are more than a little skeptical of OpenEvidence; and we've actively encouraged others to closely evaluate its outputs.
However, giving credit where credit is due, OpenEvidence opening access to medical librarians is a step in the right direction, and will allow us to get an inside look into the tool.
Now that we've got the keys to the castle, we can better search for cracks in the foundation. 🔍
Open Science Framework (OSF) recently announced that they would be phasing out projects, with the planned implementation of these changes beginning in November, 2026.
For those unfamiliar, OSF is an open-sourced project management tool commonly used for sharing and linking research records (including, but not limited to, research projects, datasets, and associated documents). The projects feature in OSF provided a centralized place for collaborating and storing files relating to a project, with options to make the project private or public. Additional information about OSF projects can be found in OSF's projects documentation.
Below is a rough timeline of OSF's upcoming changes. For the most up to date information, you can look at OSF's page detailing the changes and in their transition documentation.
Drug Story: Ivermectin by 98% Invisible
I've been wondering why MAGA glammed onto Ivermectin as being good for anything that ails you?
Our local Fleet Farm here in Oshkosh had a note on the Ivermectin bin in the horse ailse, stating that it was NOT a recognized remedy for Covid. I wish I had a photo of that sign o' the time!
Drug Story is an independent documentary podcast from journalist Thomas Goetz that explores the hidden history of medicine one drug at a time. Each episode uses a single medication to examine the science, politics, culture, and human stories surrounding disease and treatment. And they are SO good.
This week, we’re featuring one of their episodes about ivermectin, from Nobel Prize-winning anti-parasitic breakthrough to one of the most polarizing drugs of the COVID era. Along the way, the story travels from hookworm outbreaks in the American South to river blindness campaigns in West Africa, before arriving in the modern world of internet cures, medical distrust, and viral misinformation. It’s a fascinating, deeply reported story about medicine, evidence, and how a genuine wonder drug became tangled up in politics, hope, and conspiracy.
A shameless plug to check out two new tips from MLA's User Experience (UX) Caucus' Database Tips blog (the second of which is by yours truly).
Tip #69: Scopus Brackets for AcronymsHow HIV Started a Century before Anyone Noticed by Be Smart (PBS)
I came across this video last week and it made me think about the origins of HIV, and how it didn't really just appear in the 1980s, that it had been simmering a long for 100 years prior to that. It just caught fire in the 80s.
It amazes me that science is able to trace it back to the beginnings.
The Community Building and Belonging Committee along with Accessibility and Disability and Social Justice and Health Disparities Caucuses invite you to join us in sharing our stories of resilience, change, and confusion due to recent changes in our country and professional community. The hope is not only to have space for catharsis, but to share strategies for problem solving, working around, working through and resisting. An additional aim is to widen, strengthen or establish a network of support for members facing issues related to identity, community building, belonging, social justice, and/or accessibility.
Roundtables will have moderators to help guide conversation, some with defined topics for those that wish to focus on a particular issue, but others that are open for more mixed conversations. We will have a Padlet as a mechanism for recording discussions/reporting back which allows for both named and anonymous participation.
This allowed me a space to talk about my recently acquired
disabilities – I suffered a Subdural Hematoma, a traumatic brain injury, in
June of 2020. I spent June and July in the Neuro ICU and then went to a
rehabilitation facility specifically for head injury patients. I didn’t return home until December and
returned to work part time in January of 2021. I received exceptional support from my director, manager and teammates
during my hospitalization/rehab and after my return to home and work. I thought
sharing what this entailed might be helpful to others. What do you do when you or someone you work
with “get hit by a bus”? Pardon the
expression, but this is what we would say at a former job I had – be ready or
have your job documented in case someone needs to take over when you “get hit
by a bus”. Well, I did get “hit by a bus”,
but I had the support of my colleagues and my family to pull me through.
I had a very engaging conversation at my “Later in Life
Disabilities” table, and I hope I shared some pearls of wisdom with the
participants.
Some pearls of wisdom for the manager/director of someone with a later-in-life disability: